High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin (Q37695195)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 1996

edit

Language	Label	Description	Also known as
English	High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin	scientific article published on March 1996

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

title

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

main subject

doxorubicin

0 references

author

Andrew Schally

series ordinal

3

object named as

Schally AV

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

author name string

Nagy A

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

Armatis P

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

published in

Proceedings of the National Academy of Sciences of the United States of America

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

volume

93

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

issue

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

page(s)

2464-2469

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

cites work

Adriamycin, 14-hydroxydaimomycin, a new antitumor antibiotic fromS. Peucetius var.caesius

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

23 August 2017

Facile formation of a crosslinked adduct between DNA and the daunorubicin derivative MAR70 mediated by formaldehyde: molecular structure of the MAR70-d(CGTnACG) covalent adduct

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

23 August 2017

The molecular pharmacology of doxorubicin in vivo

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

23 August 2017

The anthracyclines: will we ever find a better doxorubicin?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

23 August 2017

Early anthracycline cardiotoxicity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

23 August 2017

Thermal stability of DNA adducts induced by cyanomorpholinoadriamycin in vitro.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

14 September 2017

Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

23 June 2018

Comparative cytotoxicities of various morpholinyl anthracyclines.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

23 June 2018

Characterization of the DNA-DNA cross-linking activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

23 June 2018

N-(5,5-diacetoxypentyl)doxorubicin: a novel anthracycline producing DNA interstrand cross-linking and rapid endonucleolytic cleavage in human leukemia cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

23 June 2018

N-(5,5-diacetoxypent-1-yl)doxorubicin: a new intensely potent doxorubicin analogue

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

23 June 2018

Computerized determination of growth kinetic curves and doubling times from cells in microculture.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=39820

retrieved

1 September 2018

‘Daunomycin’, a New Antibiotic of the Rhodomycin Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8637897

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

3'-(3-Cyano-4-morpholinyl)-3'-deaminoadriamycin: a new anthracycline with intense potency

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8637897

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensely potent morpholinyl anthracyclines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8637897

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues on DNA in HT-29 human colon carcinoma cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8637897

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8637897

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1073/PNAS.93.6.2464

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

ADS bibcode

1996PNAS...93.2464N

0 references

PMC publication ID

39820

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

PubMed publication ID

8637897

1 reference

stated in

Europe PubMed Central

PMC publication ID

39820

retrieved

22 August 2017

ResearchGate publication ID

14562459

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37695195&oldid=2234659018"